Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies, 2018
3.3. Porter’S Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Rise In Incidence of Cancer
3.4.1.2. Surge In Geriatric Population
3.4.2. Restraint
3.4.2.1. Stringent Approval Process
3.4.3. Opportunity
3.4.3.1. Increase In Number of Pipeline Drugs
3.4.4. Impact Analyses
Chapter 4: Oncology Drugs Market, By Drug Class Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Chemotherapy
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast,
4.3. Targeted Therapy
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast,
4.4. Immunotherapy
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast,
4.5. Hormonal Therapy
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast,
Chapter 5: Oncology Drugs Market, By Indication
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Blood Cancer
5.2.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.2.2. Market Size And Forecast
5.3. Breast Cancer
5.3.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.3.2. Market Size And Forecast
5.4. Gastrointestinal And Urinary Cancer
5.4.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.4.1.1. Market Size And Forecast
5.4.2. Gb/Cholangiocarcinoma
5.4.2.1. Market Size And Forecast
5.4.3. Bladder Cancer
5.4.3.1. Market Size And Forecast
5.4.4. Pancreatic Cancer
5.4.4.1. Market Size And Forecast
5.5. Prostate Cancer
5.5.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.5.1.1. Market Size And Forecast
5.6. Lung Cancer
5.6.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.6.1.1. Market Size And Forecast
5.6.2. Small Cell Lung Cancer
5.6.2.1. Market Size And Forecast
5.7. Skin Cancer
5.7.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.7.1.1. Market Size And Forecast
5.8. Ovarian Cancer
5.8.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.8.1.1. Market Size And Forecast
5.9. Cervical Cancer
5.9.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.9.1.1. Market Size And Forecast
5.10. Kidney Cancer
5.10.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.10.1.1. Market Size And Forecast
5.11. Other Cancers
5.11.1. Key Market Trends, Epidemiology, Growth Factors And Opportunities
5.11.1.1. Market Size And Forecast
Chapter 6: Company Profiles
6.1. Abbvie Inc.
6.1.1. Company Overview
6.1.2. Company Snapshot
6.1.3. Operating Business Segments
6.1.4. Product Portfolio
6.1.5. Business Performance
6.1.6. Key Strategic Moves And Developments: Global
6.2. Astellas Pharma Inc.
6.2.1. Company Overview
6.2.2. Company Snapshot
6.2.3. Operating Business Segments
6.2.4. Product Portfolio
6.2.5. Business Performance
6.2.6. Key Strategic Moves And Developments: Japan
6.2.7. Key Strategic Moves And Developments: Global
6.3. Astrazeneca Plc
6.3.1. Company Overview
6.3.2. Company Snapshot
6.3.3. Operating Business Segments
6.3.4. Product Portfolio
6.3.5. Business Performance
6.3.6. Key Strategic Moves And Developments: Japan
6.3.7. Key Strategic Moves And Developments: Global
6.4. Bristol-Myers Squibb Company
6.4.1. Company Overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Product Portfolio
6.4.5. Business Performance
6.4.6. Key Strategic Moves And Developments: Global
6.5. Celgene Corporation
6.5.1. Company Overview
6.5.2. Company Snapshot
6.5.3. Operating Business Segments
6.5.4. Product Portfolio
6.5.5. Business Performance
6.5.6. Key Strategic Moves And Developments: Global
6.6. Daiichi Sankyo Company, Limited
6.6.1. Company Overview
6.6.2. Company Snapshot
6.6.3. Operating Business Segments
6.6.4. Product Portfolio
6.6.5. Business Performance
6.6.6. Key Strategic Moves And Developments: Japan
6.6.7. Key Strategic Moves And Developments: Global
6.7. Hoffmann-La Roche Ag
6.7.1. Company Overview
6.7.2. Company Snapshot
6.7.3. Operating Business Segments
6.7.4. Product Portfolio
6.7.5. Business Performance
6.7.6. Key Strategic Moves And Developments: Japan
6.7.7. Key Strategic Moves And Developments: Global
6.8. Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
6.8.1. Company Overview
6.8.2. Company Snapshot
6.8.3. Operating Business Segments
6.8.4. Product Portfolio
6.8.5. Business Performance
6.8.6. Key Strategic Moves And Developments: Japan
6.8.7. Key Strategic Moves And Developments: Global
6.9. Otsuka Holdings Co., Ltd.
6.9.1. Company Overview
6.9.2. Company Snapshot
6.9.3. Operating Business Segments
6.9.4. Product Portfolio
6.9.5. Business Performance
6.9.6. Key Strategic Moves And Developments: Japan
6.9.7. Key Strategic Moves And Developments: Global
6.10. Takeda Pharmaceutical Company Ltd.
6.10.1. Company Overview
6.10.2. Company Snapshot
6.10.3. Operating Business Segments
6.10.4. Product Portfolio
6.10.5. Business Performance
6.10.6. Key Strategic Moves And Developments: Japan
6.10.7. Key Strategic Moves And Developments: Global
Table 01. Japan Oncology Drugs Market, By Drug Class Type, 2018–2026 ($Million)
Table 02. Japan Oncology Drugs Market, By Indication, 2018–2026 ($Million)
Table 03. Abbvie: Company Snapshot
Table 04. Abbvie: Operating Segments
Table 05. Abbvie: Product Portfolio
Table 06. Astellas: Company Snapshot
Table 07. Astellas: Product Portfolio
Table 08. Astrazeneca: Company Snapshot
Table 09. Astrazeneca: Operating Segments
Table 10. Astrazeneca: Product Portfolio
Table 11. Bristol-Myers Squibb: Company Snapshot
Table 12. Bristol-Myers Squibb: Product Portfolio
Table 13. Celgene: Company Snapshot
Table 14. Celgene: Operating Segments
Table 15. Celgene: Product Portfolio
Table 16. Daiichi-Sankyo: Company Snapshot
Table 17. Daiichi-Sankyo: Operating Segments
Table 18. Daiichi-Sankyo: Product Portfolio
Table 19. Roche: Company Snapshot
Table 20. Roche: Operating Segments
Table 21. Roche: Product Portfolio
Table 22. J&J: Company Snapshot
Table 23. J&J: Operating Segments
Table 24. J&J: Product Portfolio
Table 25. Otsuka: Company Snapshot
Table 26. Otsuka: Operating Segments
Table 27. Otsuka: Product Portfolio
Table 28. Takeda: Company Snapshot
Table 29. Takeda: Product Portfolio
【免責事項】
https://www.marketreport.jp/reports-disclaimer